Diagenode

>>>   Click for Diagenode’s approach to COVID-19

DNA methylation

Methylbinding domain protein

The MBD technology used in our MethylCap kit is based on the very high affinity of the MethylCap protein for methylated DNA. This protein consists of the methyl-CpG-binding domain (MBD) of human MeCP2, as a C-terminal fusion with Glutathione-S-transferase (GST) containing an N-terminal His6-tag. 

Diagenode’s MethylCap kit enables high enrichment of double-stranded DNA and a differential fractionation in function of the methylated CpG density. Fractionation reduces the complexity of samples and makes subsequent next generation sequencing easier. Prior to the MethylCap assay, DNA is first extracted and sheared using the Bioruptor® sonication device.

How it works

ADVANTAGES

  • Unaffected DNA
  • Robust & reproducible technique
  • NGS compatible

Products

Cat. No.ProductFormatPrice
C02020010 MethylCap kit
The MethylCap kit allows to specifically capture DNA fragments containing methylated CpGs. The assay is based on the affinity purification of methylated DNA ...
48 rxns $600.00
C02020011 Auto MethylCap kit
The Auto MethylCap kit allows to specifically capture DNA fragments containing methylated CpGs. The assay is based on the affinity purification of methylated...
48 rxns $535.00
C02020012 MethylCap protein
The MethylCap protein has been extensively validated for specific isolation of DNA fragments containing methylated CpGs. It consists of the methyl-CpG-bindin...
100 µg $490.00

       Site map   |   Contact us   |   Conditions of sales   |   Conditions of purchase   |   Privacy policy   |   Diagenode Diagnostics